Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK/PD of Mitiglinide in T2DM Patients with Hepatic Impairment
NCT04349696Phase 4Completed
- Sponsor
- Orient EuroPharma
- Start
- Feb 2014
- Primary completion
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of mitiglinide in type 2 diabetes mellitus (T2DM), sponsored by Orient EuroPharma. Started Feb 2014; status: completed.
02
Drugs
mitiglinide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT04349696.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04349696.